The soluble ligand of NK cell activated receptor (NKG2D) is highly expressed on the surface of exosomes secreted by prostate cancer cells, which can selectively act upon NKG2D on NK cells and CD8 + T cells and downregulate its expression. Here, CD8A is linked to prostate carcinoma.